Frank M. Fischer - 26 Apr 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role
Director
Signature
/s/ Frank Fischer
Issuer symbol
TNON
Transactions as of
26 Apr 2022
Transactions value $
$0
Form type
3
Filing time
26 Apr 2022, 21:28:35 UTC
Previous filing
04 Apr 2022
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNON Common Stock 184K 26 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNON Stock Options 26 Apr 2022 Common Stock 7.5K $5.20 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 184,466 shares of common stock issuable upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022.
F2 Frank Fischer was granted an option to purchase 15,000 shares (or 7,500 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $2.60 (or $5.20 post-split) per share with a grant date of May 7, 2021, subject to monthly equal vesting over a two-year period that commenced immediately.
F3 3,437 shares of common stock underlying stock options granted on May 7, 2021 have vested and are exercisable as of April 26, 2022.